Division of Geriatrics, Department of Internal Medicine, Konya City Hospital, University of Health Sciences, Konya, Turkey.
Department of General Surgery, Konya City Hospital, University of Health Sciences, Konya, Turkey.
Turk J Med Sci. 2023 Jun;53(3):824-834. doi: 10.55730/1300-0144.5645. Epub 2023 Jun 19.
To investigate the possible relationship between pectoralis muscle (PM) measurement and frailty in older women with breast cancer (BC) (preoperatively defined as stage 1, 2, and 3 diseases).
This retrospective, observational study was conducted at Konya Training and Research Hospital between June and December 2020. A total of 102 patients [median age 62.5 years, median follow-up period two years] were included in the study. PM measurements were obtained from thorax computerized tomography (CT). Pectoralis muscle index (PMI) was calculated by dividing the PM area by the height square of the patients (cm2/m2). Pectoralis muscle density (PMD) was evaluated using CT findings, including their Hounsfield Units (HU). Frailty status and sarcopenia-risk assessments were done by a telephone interview in September 2020 using the FRAIL index (categorized as robust or nonrobust) and SARC-F questionnaire (classified as no sarcopenia-risk or risk of sarcopenia), respectively. PM measurements were compared between robust and nonrobust patients and between patients with a risk of sarcopenia and no sarcopenia risk.
The nonrobust patients had lower pectoralis major muscle index (PMaMI) (p = 0.041) and pectoralis major muscle density(PMaD) (p = 0.020) levels than robust patients in the whole study sample. PMI (p = 0.017) and PMaMI (p = 0.010) levels were significantly lower in the nonrobust patients than in robust patients with early-stage BC. Frailty status was positively correlated with age (rho: 0.621; p < 0.001), BC stage (rho: 0.220; p = 0.026), and SARC-F score (rho: 0.747; p < 0.001), and negatively correlated with PMaMI (rho: -0.197; p = 0.047) and PMaD (rho: -0.237; p = 0.016). There were significant associations between PMaMI (OR: 0.467, 95% Confidence Interval (CI): 0.226-0.962 p = 0.039) and PMI (OR: 0.543, 95% CI: 0.299-0.986 p = 0.045) levels with frailty status (being nonrobust) in regression models.
In the study, it has been shown that pectoralis muscle assessment might be a related parameter to frailty in older women with breast cancer.
本研究旨在探讨乳腺癌(BC)老年女性(术前定义为 1、2 和 3 期疾病)中胸大肌(PM)测量与虚弱之间的可能关系。
本回顾性观察性研究于 2020 年 6 月至 12 月在科尼亚培训与研究医院进行。共纳入 102 例患者[中位年龄 62.5 岁,中位随访期为 2 年]。PM 测量是通过胸部计算机断层扫描(CT)获得的。胸大肌指数(PMI)通过将 PM 面积除以患者身高的平方(cm2/m2)来计算。使用 CT 发现包括其亨氏单位(HU)来评估胸大肌密度(PMD)。2020 年 9 月,通过电话访谈使用 FRAIL 指数(分为健壮或非健壮)和 SARC-F 问卷(无肌肉减少症风险或肌肉减少症风险)分别对虚弱状态和肌肉减少症风险进行评估。比较健壮和非健壮患者以及有肌肉减少症风险和无肌肉减少症风险患者之间的 PM 测量值。
在整个研究样本中,非健壮患者的胸大肌主要肌肉指数(PMaMI)(p = 0.041)和胸大肌主要肌肉密度(PMaD)(p = 0.020)水平低于健壮患者。非健壮患者的 PMI(p = 0.017)和 PMaMI(p = 0.010)水平明显低于早期 BC 的健壮患者。虚弱状态与年龄(rho:0.621;p < 0.001)、BC 分期(rho:0.220;p = 0.026)和 SARC-F 评分(rho:0.747;p < 0.001)呈正相关,与 PMaMI(rho:-0.197;p = 0.047)和 PMaD(rho:-0.237;p = 0.016)呈负相关。PMaMI(OR:0.467,95%置信区间(CI):0.226-0.962,p = 0.039)和 PMI(OR:0.543,95%CI:0.299-0.986,p = 0.045)水平与回归模型中的虚弱状态(非健壮)之间存在显著关联。
在这项研究中,已经表明胸大肌评估可能是乳腺癌老年女性虚弱的相关参数。